| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $3.3B | $3.1B | $2.6B | $1.4B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | $0.4B | $0.6B | $0.6B | $0.2B |
| Net Income | $0.2B | $0.4B | $0.5B | $0.2B |
| EPS (Basic) | $1.36 | $3.01 | $3.48 | $1.99 |
| EPS (Diluted) | $1.35 | $2.96 | $3.32 | $1.73 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $7.5B | $8.0B | $5.5B | $5.2B |
| Current Assets | $1.3B | $1.4B | $1.1B | $1.1B |
| Cash & Equivalents | $0.5B | $0.2B | $0.4B | $0.5B |
| Total Liabilities | $3.0B | $3.3B | $1.6B | $1.6B |
| Current Liabilities | $0.8B | $0.9B | $0.6B | $0.7B |
| Stockholders' Equity | $4.5B | $4.7B | $3.9B | $3.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.7B | $0.6B | $0.3B |
| Investing Cash Flow | $-0.4B | $-1.0B | $-0.4B | $0.4B |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $-0.4B | $0.2B | $-0.3B | $-0.4B |